162 related articles for article (PubMed ID: 38822413)
1. The effect of cannabis edibles on driving and blood THC.
Zhao S; Brands B; Kaduri P; Wickens CM; Hasan OSM; Chen S; Le Foll B; Di Ciano P
J Cannabis Res; 2024 May; 6(1):26. PubMed ID: 38822413
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and Driving in Older Adults.
Di Ciano P; Rajji TK; Hong L; Zhao S; Byrne P; Elzohairy Y; Brubacher JR; McGrath M; Brands B; Chen S; Wang W; Hasan OSM; Wickens CM; Kaduri P; Le Foll B
JAMA Netw Open; 2024 Jan; 7(1):e2352233. PubMed ID: 38236599
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
[No Abstract] [Full Text] [Related]
5. Simulated driving performance among daily and occasional cannabis users.
Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
[TBL] [Abstract][Full Text] [Related]
6. The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving.
Di Ciano P; Brands B; Fares A; Wright M; Stoduto G; Byrne P; McGrath M; Hasan OSM; Le Foll B; Wickens CM
Cannabis Cannabinoid Res; 2023 Jun; 8(3):408-413. PubMed ID: 36730769
[No Abstract] [Full Text] [Related]
7. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
8. Cannabis effects on driving lateral control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
[TBL] [Abstract][Full Text] [Related]
9. The failings of
Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
[TBL] [Abstract][Full Text] [Related]
10. Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive.
Miller R; Brown T; Schmitt R; Gaffney G; Milavetz G
Accid Anal Prev; 2024 Feb; 195():107376. PubMed ID: 37984112
[TBL] [Abstract][Full Text] [Related]
11. Cannabis effects on driving longitudinal control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
[TBL] [Abstract][Full Text] [Related]
12. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
[TBL] [Abstract][Full Text] [Related]
13. Form and content of Jamaican cannabis edibles.
Lindsay CM; Abel WD; Jones-Edwards EE; Brown PD; Bernard KK; Taylor TT
J Cannabis Res; 2021 Jul; 3(1):29. PubMed ID: 34243817
[TBL] [Abstract][Full Text] [Related]
14. Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability - a randomized clinical trial.
Egloff L; Frei P; Gerlach K; Mercer-Chalmers-Bender K; Scheurer E
Int J Legal Med; 2023 Nov; 137(6):1713-1723. PubMed ID: 37626214
[TBL] [Abstract][Full Text] [Related]
15. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.
Manning B; Arkell TR; Hayley AC; Downey LA
J Psychopharmacol; 2024 Mar; 38(3):247-257. PubMed ID: 38332655
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".
Hädener M; Gelmi TJ; Martin-Fabritius M; Weinmann W; Pfäffli M
Int J Legal Med; 2019 May; 133(3):821-832. PubMed ID: 30612324
[TBL] [Abstract][Full Text] [Related]
18. Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors.
Goulette M; Schlienz NJ; Case AA; Hansen E; Rivard C; Ashare RL; Goniewicz ML; Bansal-Travers M; Hyland A; Smith DM
Support Care Cancer; 2024 Mar; 32(4):210. PubMed ID: 38443674
[TBL] [Abstract][Full Text] [Related]
19. THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles.
Goodman S; Hammond D
J Cannabis Res; 2022 Apr; 4(1):17. PubMed ID: 35387681
[TBL] [Abstract][Full Text] [Related]
20. Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving.
Shahidi Zandi A; Comeau FJE; Mann RE; Di Ciano P; Arslan EP; Murphy T; Le Foll B; Wickens CM
Cannabis Cannabinoid Res; 2021 Dec; 6(6):537-547. PubMed ID: 34432541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
